loading
Schlusskurs vom Vortag:
$7.06
Offen:
$7
24-Stunden-Volumen:
417.81K
Relative Volume:
0.70
Marktkapitalisierung:
$604.41M
Einnahmen:
$81.18M
Nettoeinkommen (Verlust:
$-80.94M
KGV:
-6.0124
EPS:
-1.1809
Netto-Cashflow:
$-55.15M
1W Leistung:
-2.74%
1M Leistung:
-10.80%
6M Leistung:
+40.04%
1J Leistung:
+65.50%
1-Tages-Spanne:
Value
$6.83
$7.2064
1-Wochen-Bereich:
Value
$7.01
$7.69
52-Wochen-Spanne:
Value
$3.75
$8.98

Sophia Genetics Sa Stock (SOPH) Company Profile

Name
Firmenname
Sophia Genetics Sa
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
415
Name
Twitter
Name
Nächster Verdiensttermin
2026-11-03
Name
Neueste SEC-Einreichungen
Name
SOPH's Discussions on Twitter

Compare SOPH vs VEEV, TEM, BTSG, HNGE, HQY

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SOPH icon
SOPH
Sophia Genetics Sa
7.10 604.41M 81.18M -80.94M -55.15M -1.1809
VEEV icon
VEEV
Veeva Systems Inc
312.46 50.59B 3.32B 941.65M 1.64B 5.6161
TEM icon
TEM
Tempus Ai Inc
69.08 12.54B 1.36B -302.91M -219.93M -1.7182
BTSG icon
BTSG
Brightspring Health Services Inc
62.41 12.35B 13.65B 169.86M 412.12M 1.0758
HNGE icon
HNGE
Hinge Health Inc
105.36 8.50B 646.34M -512.40M 202.76M -6.6871
HQY icon
HQY
Healthequity Inc
92.42 7.64B 1.34B 230.70M 440.96M 2.6695

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-07-20 Eingeleitet H.C. Wainwright Buy
2024-12-18 Eingeleitet Craig Hallum Buy
2024-08-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-06-27 Eingeleitet Guggenheim Buy
2023-11-29 Eingeleitet RBC Capital Mkts Outperform
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-01-03 Eingeleitet BTIG Research Buy
2022-11-23 Eingeleitet Credit Suisse Neutral
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-17 Eingeleitet Cowen Outperform
2021-08-17 Eingeleitet Credit Suisse Outperform
2021-08-17 Eingeleitet JP Morgan Overweight
2021-08-17 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

pulisher
Oct 08, 2026

SOPHiA GENETICS SA Ordinary Shares (SOPH) Stock Price: Oct 7 Close $7.15 - Gotrade

Oct 08, 2026
pulisher
Oct 07, 2026

SOPHiA GENETICS CSO Kevin Puylaert Sells 216 Shares for RSU Tax Withholding on October 5, 2026 - Kalkine Media

Oct 07, 2026
pulisher
Oct 07, 2026

SOPHiA GENETICS CMO Philippe Menu Sells 7,394 Shares to Cover RSU Tax Withholdings - Kalkine Media

Oct 07, 2026
pulisher
Oct 07, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Insider Well Daan Van Sells 6,168 Shares of Company Stock - MarketBeat

Oct 07, 2026
pulisher
Oct 07, 2026

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 7,394 Shares of Company Stock - MarketBeat

Oct 07, 2026
pulisher
Oct 07, 2026

Tax withholding drives legal chief’s 6,168-share sale at SOPHiA GENETICS (SOPH) - Stock Titan

Oct 07, 2026
pulisher
Oct 05, 2026

SOPHiA GENETICS Director Ross J. Muken Files Form 144 for Sale of 9,838 Shares Under 10b5-1 Plan - Kalkine Media

Oct 05, 2026
pulisher
Oct 05, 2026

An officer plans to sell 19,394 common shares in SOPHiA GENETICS (SOPH). - Stock Titan

Oct 05, 2026
pulisher
Oct 05, 2026

An officer proposes selling 6,168 SOPHiA GENETICS (NASDAQ: SOPH) shares after stock grants vest. - Stock Titan

Oct 05, 2026
pulisher
Oct 05, 2026

9,838 shares are proposed for sale by Ross J. Muken at SOPHiA GENETICS (SOPH), valued at $79.4K. - Stock Titan

Oct 05, 2026
pulisher
Oct 05, 2026

Officer George Cardoza proposes selling 1,592 SOPHiA GENETICS (SOPH) common shares. - Stock Titan

Oct 05, 2026
pulisher
Oct 05, 2026

Founder shares feature in Jurgi Camblong’s proposed $530K SOPHiA GENETICS (Nasdaq: SOPH) sale. - Stock Titan

Oct 05, 2026
pulisher
Sep 22, 2026

SOPHiA GENETICS CEO Ross Muken Sells 422 Shares to Cover RSU Tax Withholding - Kalkine Media

Sep 22, 2026
pulisher
Sep 22, 2026

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - Eastern Progress

Sep 22, 2026
pulisher
Sep 21, 2026

Officer at SOPHiA GENETICS (NASDAQ: SOPH) lines up 774-share sale after 10b5-1 trades - Stock Titan

Sep 21, 2026
pulisher
Sep 21, 2026

Planned sale of 422 SOPHiA GENETICS (SOPH) shares disclosed under Rule 144 - Stock Titan

Sep 21, 2026
pulisher
Sep 18, 2026

SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance

Sep 18, 2026
pulisher
Sep 17, 2026

SOPHiA GENETICS (NASDAQ: SOPH) Insider Xu Zhenyu Retains 552,887 Shares Following Sale - Kalkine Media

Sep 17, 2026
pulisher
Sep 17, 2026

SOPHiA GENETICS SA (NASDAQ: SOPH) Executive Menu Philippe Disposes of 5,000 Shares at $7.88 Each - Kalkine Media

Sep 17, 2026
pulisher
Sep 16, 2026

SOPHiA GENETICS CSO Xu Zhenyu Sells 4,000 Shares Under Rule 10b5-1 Plan - Kalkine Media

Sep 16, 2026
pulisher
Sep 15, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeShould You Buy? - marketbeat.com

Sep 15, 2026
pulisher
Sep 15, 2026

SOPHiA GENETICS Insider Van Well Daan Sells 6,168 Shares at $7.63 Each (NASDAQ: SOPH) - Kalkine Media

Sep 15, 2026
pulisher
Sep 11, 2026

Officer at SOPHiA GENETICS (NASDAQ: SOPH) to sell 6,168 shares - Stock Titan

Sep 11, 2026
pulisher
Sep 11, 2026

SOPHiA GENETICS SA (NASDAQ:SOPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Sep 11, 2026
pulisher
Sep 10, 2026

Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Director Sells $50,812.50 in Stock - MarketBeat

Sep 10, 2026
pulisher
Sep 10, 2026

SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares via 10b5-1 Trading Plan - Kalkine Media

Sep 10, 2026
pulisher
Sep 09, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Shares Down 8.3%Time to Sell? - MarketBeat

Sep 09, 2026
pulisher
Sep 09, 2026

Maven Securities LTD Invests $866,000 in SOPHiA GENETICS SA $SOPH - MarketBeat

Sep 09, 2026
pulisher
Sep 04, 2026

SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise - Yahoo Finance

Sep 04, 2026
pulisher
Sep 02, 2026

SOPHiA GENETICS (NASDAQ:SOPH): Is Volume Signaling A Shift? - Kalkine Media

Sep 02, 2026
pulisher
Sep 01, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Sees Large Volume IncreaseHere's Why - marketbeat.com

Sep 01, 2026
pulisher
Aug 31, 2026

SOPHiA GENETICS CSO Zhenyu Xu Sells 10,000 Shares Under Rule 10b5-1 Plan - Kalkine Media

Aug 31, 2026
pulisher
Aug 31, 2026

Zhenyu Xu Sells 10,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat

Aug 31, 2026
pulisher
Aug 28, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Down 5%Here's Why - MarketBeat

Aug 28, 2026
pulisher
Aug 27, 2026

Sophia Genetics SA (SOPH) Peer Comparison – Compare with Others - Value Research

Aug 27, 2026
pulisher
Aug 27, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer to sell 14K founder shares - Stock Titan

Aug 27, 2026
pulisher
Aug 26, 2026

SOPHiA GENETICS Director Kathy L. Hibbs Sells 6,250 Shares Under Rule 10b5-1 Plan - Kalkine Media

Aug 26, 2026
pulisher
Aug 26, 2026

SOPHiA GENETICS CTO Abhimanyu Verma Executes Sale of 10,000 Shares in August 2026 - Kalkine Media

Aug 26, 2026
pulisher
Aug 25, 2026

SOPHiA GENETICS (NASDAQ: SOPH) director plans $158K stock sale - Stock Titan

Aug 25, 2026
pulisher
Aug 24, 2026

SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move: Shares Move Lower 2.31% in Latest TradingEarnings Stability Report - dars.gov.et

Aug 24, 2026
pulisher
Aug 24, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Sees Strong Trading VolumeHere's What Happened - marketbeat.com

Aug 24, 2026
pulisher
Aug 24, 2026

SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move - careplusvn.com

Aug 24, 2026
pulisher
Aug 24, 2026

SOPHiA (SOPH) Earnings Update: The Available Earnings Metric Delivers a Miss in the Available Record; Share Move: Shares Move Lower 2.31% in Latest TradingRevenue Surprise History - dars.gov.et

Aug 24, 2026
pulisher
Aug 21, 2026

SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu Sells 20,000 Shares Over Three Days - Kalkine Media

Aug 21, 2026
pulisher
Aug 21, 2026

SOPHiA GENETICS CPO Manuela Valente Executes Share Option Exercise and Sale - Kalkine Media

Aug 21, 2026
pulisher
Aug 20, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer may sell founder shares - Stock Titan

Aug 20, 2026
pulisher
Aug 19, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer lines up 10,000-share sale - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

SOPHiA GENETICS (NASDAQ: SOPH) officer plans additional 8,000-share sale - Stock Titan

Aug 19, 2026
pulisher
Aug 19, 2026

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month HighShould You Buy? - MarketBeat

Aug 19, 2026
pulisher
Aug 19, 2026

EBIT per share of SOPHiA GENETICS SA – DUS:90B - TradingView

Aug 19, 2026

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Sophia Genetics Sa-Aktie (SOPH) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Xu Zhenyu
Chief Scientific Officer
Oct 13 '26
Sale
7.18
4,000
28,727
541,493
Camblong Jurgi
Executive Chairman
Oct 12 '26
Sale
7.26
8,500
61,671
3,387,150
ROSS J MUKEN
Director
Oct 05 '26
Proposed Sale
8.07
9,838
79,393
0
PHILIPPE MENU
Officer
Oct 05 '26
Proposed Sale
8.07
22,394
180,720
0
MANUELA VALENTE
Officer
Oct 05 '26
Proposed Sale
8.07
4,240
34,217
0
GEORGE CARDOZA
Officer
Oct 05 '26
Proposed Sale
8.07
1,592
12,847
0
JURGI CAMBLONG
Director
Oct 05 '26
Proposed Sale
8.07
65,672
529,973
0
Valente Manuela
Chief People Officer
Oct 05 '26
Sale
8.13
4,240
34,487
206,210
Verma Abhimanyu
Chief Technology Officer
Oct 05 '26
Sale
8.12
5,284
42,929
166,887
Van Well Daan
Chief Legal Officer
Oct 05 '26
Sale
8.12
6,168
50,100
332,716
$7.39
price up icon 0.00%
EVH EVH
$4.97
price up icon 5.07%
PHR PHR
$10.93
price up icon 2.82%
NRC NRC
$21.23
price up icon 3.94%
$23.79
price down icon 0.65%
Kapitalisierung:     |  Volumen (24h):